Establishment Labs Reports Strong Q4 & FY25 Results, Achieves Positive Adjusted EBITDA, and Projects Robust 2026 Guidance with Positive Cash Flow

summarizeSummary

Establishment Labs announced strong Q4 and full year 2025 financial results, including positive adjusted EBITDA, and provided robust 2026 revenue guidance with a clear path to positive cash flow.

check_boxKey Events

• Strong Q4 and Full Year 2025 Financial Results

  Reported Q4 2025 revenue of $64.6 million, a 45.2% increase year-over-year, and full year 2025 revenue of $211.1 million, up 27.2% from 2024.

• Significant Improvement in Profitability

  Achieved positive adjusted EBITDA of $5.5 million in Q4 2025, an $18.6 million increase from a loss in the prior year, and reduced net loss from operations by 79% to $3.9 million.

• Robust 2026 Revenue Guidance

  Provided 2026 revenue guidance of $264 million to $266 million, representing 25.1% to 26.0% growth over 2025, with 2027 revenue growth projected at least 25%.

• Path to Positive Cash Flow

  The company is positioned for its first quarter of positive cash flow in 2026 and expects positive cash flow for the full year 2027.

auto_awesomeAnalysis

Establishment Labs reported strong financial performance for Q4 and full year 2025, marked by substantial revenue growth and a significant reduction in net loss. A key positive is the achievement of positive adjusted EBITDA in Q4 2025 and the projection for positive cash flow in Q1 2026 and for the full year 2027. The robust 2026 revenue guidance of $264 million to $266 million, representing 25.1% to 26.0% growth, along with a 25% growth projection for 2027, indicates strong operational momentum and a clear path to sustained profitability. This filing confirms the positive outlook previously hinted at in earlier preliminary reports and conference presentations, providing definitive numbers and forward-looking statements that are likely to reinforce investor confidence, especially as the stock is trading near its 52-week high.